Cardiothoracic surgeon Dr. Joseph Cleveland gives his view on how the VALOR-HCM trial might impact the treatment of obstructive hypertrophic cardiomyopathy (HCM).
ReachMD
Be part of the knowledge.™Impact of New First-in-Class Medical Therapy in Obstructive HCM
Choose a format
Media formats available:
Facebook Comments